Munafa Stock Market Course + Intraday & FNO calls 
Aclaris Therapeutics (ACRS) Technical (Analysis) Reports Aclaris Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Aclaris Therapeutics (ACRS)
Technical Analysis Report for USA stock ACRS Aclaris Therapeutics. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ACRS Aclaris Therapeutics then click here. or read Experts views on Aclaris Therapeutics or Forecast & share price targets of Aclaris Therapeutics
Aclaris Therapeutics Opened at 4.63 and Closed at: 4.42, which is -4.75% of previous session's close. It moved within a range of 4.40 and 4.66
The session was a Bearish session with an average volume of 1578900, which is 4.35% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 7 days back on short term averages
Support for tomorrow is 4.28 and resistance for tomorrow is 4.54
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.33, 4.23 resistance for tomorrow's hourly charts is 4.59, 4.75
10 Day SMA for Aclaris Therapeutics (ACRS) is 4.52 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Aclaris Therapeutics (ACRS) is 4.64 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Aclaris Therapeutics (ACRS) is 4.33 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 3.87 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Aclaris Therapeutics is 3.11 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Aclaris Therapeutics is at 4.64 and 200 DMA is at 3.11, while 50 DMA and 100 DMA are at 4.33 and 3.87 respectively
Aclaris Therapeutics (ACRS) moving average of 20 SMA is at 4.64 and 20 EMA is at 4.54
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 4.42 | 4.64 | 4.54 |
| 02 Tue Jun | 4.63 | 4.66 | 4.55 |
| 01 Mon Jun | 4.34 | 4.67 | 4.54 |
| 29 Fri May | 4.55 | 4.68 | 4.56 |
| 28 Thu May | 4.57 | 4.67 | 4.56 |
| 27 Wed May | 4.58 | 4.66 | 4.56 |
Aclaris Therapeutics (ACRS) moving average of 50 SMA is at 4.33 and 50 EMA is at 4.3
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 4.42 | 4.33 | 4.3 |
| 02 Tue Jun | 4.63 | 4.3 | 4.3 |
| 01 Mon Jun | 4.34 | 4.28 | 4.29 |
| 29 Fri May | 4.55 | 4.27 | 4.29 |
| 28 Thu May | 4.57 | 4.25 | 4.28 |
| 27 Wed May | 4.58 | 4.24 | 4.27 |
Aclaris Therapeutics (ACRS) moving average of 100 SMA is at 3.87 and 100 EMA is at 3.9
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 4.42 | 3.87 | 3.9 |
| 02 Tue Jun | 4.63 | 3.85 | 3.89 |
| 01 Mon Jun | 4.34 | 3.83 | 3.87 |
| 29 Fri May | 4.55 | 3.81 | 3.86 |
| 28 Thu May | 4.57 | 3.79 | 3.85 |
| 27 Wed May | 4.58 | 3.78 | 3.84 |
Aclaris Therapeutics (ACRS) moving average of 200 SMA is at 3.11 and 200 EMA is at 3.33
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 4.42 | 3.11 | 3.33 |
| 02 Tue Jun | 4.63 | 3.09 | 3.32 |
| 01 Mon Jun | 4.34 | 3.08 | 3.31 |
| 29 Fri May | 4.55 | 3.07 | 3.3 |
| 28 Thu May | 4.57 | 3.05 | 3.29 |
| 27 Wed May | 4.58 | 3.04 | 3.28 |
Aclaris Therapeutics has performed better than Inspire Medical in short term. Holding Aclaris Therapeutics could be a better choice for now!
Veracyte Inc has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Veracyte Inc, about 25.74% more returns!
Aclaris Therapeutics has performed better than Sutro Biopharma in short term. Holding Aclaris Therapeutics could be a better choice for now!
Sol Gel has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Sol Gel, about 7.67% more returns!
Quidel Corporation has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Quidel Corporation, about 31.62% more returns!
Oncolytics Biotech has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 3.18% more returns!
Neurocrine Biosciences has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 19.83% more returns!
Merit Medical has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 5.94% more returns!
Aclaris Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. Holding Aclaris Therapeutics could be a better choice for now!
Kala Pharmaceuticals has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 1774.2% more returns!
Aclaris Therapeutics has performed better than Intuitive Surgical in short term. Holding Aclaris Therapeutics could be a better choice for now!
Aclaris Therapeutics has performed better than Irhythm Technologies in short term. Holding Aclaris Therapeutics could be a better choice for now!
Ensign Group has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 2.27% more returns!
Aclaris Therapeutics has performed better than Cytomx Therapeutics in short term. Holding Aclaris Therapeutics could be a better choice for now!
Cooper Companies has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Cooper Companies, about 6.25% more returns!
Array Biopharma has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 14.91% more returns!
Amgen Inc has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 9.71% more returns!
Agios Pharmaceuticals has performed better than Aclaris Therapeutics in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 10.12% more returns!
Aclaris Therapeutics Technical analysis of indicators
Price action analysis of Aclaris Therapeutics (ACRS) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aclaris Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.49 and Aclaris Therapeutics ACRS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics ACRS stock. Volume based technical analysis of Aclaris Therapeutics ACRS stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ACRS Aclaris Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ACRS Experts View which covers a lot of information including buying and selling signals
ACRS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aclaris Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Aclaris Therapeutics (ACRS) Technical (Analysis) Reports Aclaris Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
